Back to Agenda
Session 5 Track 3: Novel and Emerging Technologies
Session Chair(s)
Paul Minne, PharmD, RPh
Senior Director, MSL Team
Neurocrine Biosciences, United States
Kay Uttech, PharmD, MA, RPh
VP, Strategic Initiatives
Indegene, United States
This session will incorporate real life cases and panel discussions showing how technology can turn a problem into a solution. We will highlight uses of new technologies and discuss ways to potentially incorporate them into producing results for Medical Affairs teams. Emerging technology applications into medical affairs best practices and implications for organizations change will be the center of the dialogue.
Learning Objective : At the conclusion of this session, participants should be able to:
- Interpret digital literacy to compare and contrast the impact that technology has on Medical Affairs
- Apply technology solutions to common issues and landscape changes occurring in industry
- Assess the potential future benefits of virtual reality, artificial intelligence, and machine learning and their implications for Medical Affairs
Speaker(s)
What Problem are we Solving?
Chris Wasden, EdD, MBA
Happify Health, United States
Head of Pharma Specialty Solutions and Corporate Strategy
Tools to Change Medical Affairs
Colin Baughman, MBA
True North Solutions Inc., United States
Managing Partner and Founder
Field Medical Perspectives
Christy Cheung, PharmD, RPh
Sanofi, Canada
Lead, Digital Innovation & Transformation
Have an account?